UroGen Pharma Ltd. - stock earnings
URGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -21.9 million USD | 20.9 million USD |
| 2023Q2 | -24.1 million USD | 21.1 million USD |
| 2023Q1 | -30.2 million USD | 17.2 million USD |
| 2022Q4 | -28.2 million USD | 18.1 million USD |
| 2022Q3 | -25.8 million USD | 16.1 million USD |
| 2022Q2 | -26.7 million USD | 16.6 million USD |
| 2022Q1 | -28.4 million USD | 13.6 million USD |
| 2021Q4 | -28.5 million USD | 16.2 million USD |
| 2021Q3 | -30.2 million USD | 11.4 million USD |
| 2021Q2 | -26.2 million USD | 13.0 million USD |
| 2021Q1 | -25.9 million USD | 7.5 million USD |
| 2020Q4 | -30.5 million USD | 8.0 million USD |
| 2020Q3 | -28.8 million USD | 3.5 million USD |
| 2020Q2 | -31.3 million USD | 372000 USD |
| 2020Q1 | -37.8 million USD | ? USD |
| 2019Q4 | -39.0 million USD | ? USD |
| 2019Q3 | -22.3 million USD | ? USD |
| 2019Q2 | -22.5 million USD | 18000 USD |
| 2019Q1 | -21.4 million USD | ? USD |
| 2018Q4 | -23.7 million USD | 845000 USD |
| 2018Q3 | -20.5 million USD | 283000 USD |
| 2018Q2 | -18.0 million USD | 364000 USD |
| 2018Q1 | -13.4 million USD | 481000 USD |
| 2017Q4 | -10.1 million USD | 327000 USD |
| 2017Q3 | -298000 USD | 7.8 million USD |
| 2017Q2 | -6.2 million USD | 38000 USD |
| 2017Q1 | -3.4 million USD | 19000 USD |
| 2016Q4 | 12.9 million USD | 17.5 million USD |
| 2016Q3 | -8.0 million USD | ? USD |
| 2016Q2 | -3.3 million USD | ? USD |
| 2015Q4 | -12.7 million USD | ? USD |
URGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -105.1 million USD | 77.3 million USD |
| 2022 | -109.2 million USD | 64.4 million USD |
| 2021 | -110.8 million USD | 48.0 million USD |
| 2020 | -128.5 million USD | 11.8 million USD |
| 2019 | -100.5 million USD | 18000 USD |
| 2018 | -75.7 million USD | 1.1 million USD |
| 2017 | -20.0 million USD | 8.2 million USD |
| 2016 | -1.9 million USD | 17.5 million USD |
| 2015 | -12.7 million USD | ? USD |
| 2014 | -4.5 million USD | ? USD |
| 2013 | -3.3 million USD | ? USD |
URGN
Price: $14.26
52 week price:
Earnings Per Share: -3.55 USD
P/E Ratio: -3.83
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 20983
Ebitda: -286000Market Capitalization: 452.1 million